Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models
Viruses · 2023
DOI: 10.3390/v15040828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Yasmin Shakiba und 12 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia. Hauptthemen laut MEDLINE: Melanoma, Experimental, Oncolytic Viruses, Oncolytic Virotherapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Oncolytic viral therapy is a promising novel approach to cancer treatment. Oncolytic viruses cause tumor regression through direct cytolysis on the one hand and recruiting and activating immune cells on the other. In this study, to enhance the antitumor efficacy of the thymidine kinase-deficient vaccinia virus (VV, Lister strain), recombinant variants encoding bacterial flagellin (subunit B) of Vibrio vulnificus (LIVP-FlaB-RFP), firefly luciferase (LIVP-Fluc-RFP) or red fluorescent protein (LIVP-RFP) were developed. The LIVP-FLuc-RFP strain demonstrated exceptional onco-specificity in tumor-bearing mice, detected by the in vivo imaging system (IVIS). The antitumor efficacy of these variants was explored in syngeneic murine tumor models (B16 melanoma, CT26 colon cancer and 4T1 breast cancer). After intravenous treatment with LIVP-FlaB-RFP or LIVP-RFP, all mice tumor models exhibited tumor regression, with a prolonged survival rate in comparison with the control mice. However, superior oncolytic activity was observed in the B16 melanoma models treated with LIVP-FlaB-RFP. Tumor-infiltrated lymphocytes and the cytokine analysis of the serum and tumor samples from the melanoma-xenografted mice treated with these virus variants demonstrated activation of the host’s immune response. Thus, the expression of bacterial flagellin by VV can enhance its oncolytic efficacy against immunosuppressive solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
- Department of Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation, 119034 Moscow, Russia.
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.
- Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia.
ORCID-Profile: Yasmin Shakiba, Pavel O Vorobyev, Gaukhar M Yusubalieva, Peter M Chumakov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Shakiba, Y., Vorobyev, P. O., Naumenko, V. A., Kochetkov, D. V., Zajtseva, K. V., Valikhov, M. P., Yusubalieva, G. M., Gumennaya, Y. D., Emelyanov, E. A., Semkina, A. S., Baklaushev, V. P., Chumakov, P. M., & Lipatova, A. V. (2023). Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models. Viruses. https://doi.org/10.3390/v15040828
Vancouver
Shakiba Y, Vorobyev PO, Naumenko VA, Kochetkov DV, Zajtseva KV, Valikhov MP, et al. Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models. Viruses. 2023. doi:10.3390/v15040828
BibTeX
@article{Shakiba2023,
author = {Shakiba, Yasmin and Vorobyev, Pavel O and Naumenko, Victor A and Kochetkov, Dmitry V and Zajtseva, Ksenia V and Valikhov, Marat P and Yusubalieva, Gaukhar M and Gumennaya, Yana D and Emelyanov, Egor A and Semkina, Alevtina S and Baklaushev, Vladimir P and Chumakov, Peter M and Lipatova, Anastasia V},
title = {Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040828}
}
EUVIMED